RecruitingPhase 2Phase 3NCT07688551

Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation

Transcranial Direct Current Stimulation to Treat Aphasia: A Superiority Study


Sponsor

University of South Carolina

Enrollment

130 participants

Start Date

Jul 14, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to help us understand if adding transcranial Direct Current Stimulation (tDCS), a non-invasive brain stimulation technique, to Speech Therapy improves language recovery in people with Broca's aphasia and is more effective than Speech Therapy alone.


Eligibility

Min Age: 25 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called tDCS for people with aphasia and broca's aphasia. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 25 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtDCS

The study intervention will be delivered using the Soterix 1x1 Transcranial Electrical Stimulation Clinical Trials device (Soterix Medical Inc., New York).


Locations(3)

Medical University of South Carolina

Charleston, South Carolina, United States

University of South Carolina

Columbia, South Carolina, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07688551


Related Trials